European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

The Sokal and Hasford scores were developed in the chemotherapy and interferon era and are widely used as prognostic indicators in patients with chronic myeloid leukemia (CML). Recently, a new European Treatment and Outcome Study (EUTOS) scoring system was developed. We performed a multicenter retro...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Sci
Главные авторы: Yamamoto, Eri, Fujisawa, Shin, Hagihara, Maki, Tanaka, Masatsugu, Fujimaki, Katsumichi, Kishimoto, Kumiko, Hashimoto, Chizuko, Itabashi, Megumi, Ishibashi, Daisuke, Nakajima, Yuki, Tachibana, Takayoshi, Kawasaki, Rika, Kuwabara, Hideyuki, Koharazawa, Hideyuki, Yamazaki, Etsuko, Tomita, Naoto, Sakai, Rika, Fujita, Hiroyuki, Kanamori, Heiwa, Ishigatsubo, Yoshiaki
Формат: Artigo
Язык:Inglês
Опубликовано: BlackWell Publishing Ltd 2014
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317875/
https://ncbi.nlm.nih.gov/pubmed/24450386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12321
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы